Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.

Whatley KCL, Padalino G, Whiteland H, Geyer KK, Hulme BJ, Chalmers IW, Forde-Thomas J, Ferla S, Brancale A, Hoffmann KF.

PLoS Negl Trop Dis. 2019 Nov 15;13(11):e0007693. doi: 10.1371/journal.pntd.0007693. eCollection 2019 Nov.

2.

Erratum to 'Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni' [IJP Drugs Drug Resist. 8 (2018) 559-570].

Padalino G, Ferla S, Brancale A, Chalmers IW, Hoffmann KF.

Int J Parasitol Drugs Drug Resist. 2019 Aug;10:91. doi: 10.1016/j.ijpddr.2019.07.001. Epub 2019 Jul 2. No abstract available.

3.

Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.

Padalino G, Ferla S, Brancale A, Chalmers IW, Hoffmann KF.

Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):559-570. doi: 10.1016/j.ijpddr.2018.10.005. Epub 2018 Nov 13. Erratum in: Int J Parasitol Drugs Drug Resist. 2019 Aug;10:91.

4.

Histone methylation changes are required for life cycle progression in the human parasite Schistosoma mansoni.

Roquis D, Taudt A, Geyer KK, Padalino G, Hoffmann KF, Holroyd N, Berriman M, Aliaga B, Chaparro C, Grunau C, Augusto RC.

PLoS Pathog. 2018 May 21;14(5):e1007066. doi: 10.1371/journal.ppat.1007066. eCollection 2018 May.

5.

(Epi)genetic Inheritance in Schistosoma mansoni: A Systems Approach.

Cosseau C, Wolkenhauer O, Padalino G, Geyer KK, Hoffmann KF, Grunau C.

Trends Parasitol. 2017 Apr;33(4):285-294. doi: 10.1016/j.pt.2016.12.002. Epub 2016 Dec 28. Review.

Supplemental Content

Loading ...
Support Center